Drugs News and Research

RSS

Study indicates ocular shingles may increase stroke risk

Having a shingles infection that affects the eyes may increase the risk of stroke, according to new research published in the March 3, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

4 Mar 2010

Survey underscores need for continued efforts to combat substance abuse among teens

New survey data released today by the Partnership for a Drug-Free America and MetLife Foundation point to the need for continued efforts to combat substance abuse among teens. While there was no significant increase in the abuse of over-the-counter (OTC) cough medicines containing dextromethorphan, the 21st annual Partnership/MetLife Foundation Attitude Tracking Survey (PATS) found an overall waning in teens' negative perceptions about many drugs along with increases in abuse rates for alcohol, ecstasy, and marijuana.

3 Mar 2010

Gene 'addiction' of leukaemia cells

An international team of scientists studying acute forms of Leukaemia have identified a new drug target to inhibit the genes which are vital for the growth of diseased cells. The research, reported in EMBO Molecular Medicine, reveals how leukaemia cells become 'addicted' to genes, which if targeted could prevent diseased cells from developing.

3 Mar 2010

Seattle Genetics generates $110M through ADC technology license agreements

Seattle Genetics, Inc. announced today that it has achieved a milestone under its antibody-drug conjugate (ADC) collaboration with Genentech, Inc., a wholly owned member of the Roche Group.

3 Mar 2010

YM BioSciences files Form 6K regarding certain nimotuzumab US patents

YM BioSciences Inc., announces that it filed a Form 6K describing that certain US patents for nimotuzumab licensed to YM's majority-owned Canadian subsidiary , CIMYM BioSciences Inc., have become subject to a lien in the United States, pursuant to a court order, to a third party.

3 Mar 2010

PCMA releases statement on GAO report that examines specialty-tier prescription drugs in Medicare Part D

“Meaningful biogenerics legislation should be the first stop for policymakers tasked with financing health reform. PCMA and a broad coalition of consumers, employers, labor unions, and others support bipartisan legislation that would create a regulatory pathway for the Food and Drug Administration to approve generic versions of biologic products.”

3 Mar 2010

Step-up treatments may benefit children with asthma on low-dose inhaled corticosteroids

Children with asthma who continue to have symptoms while using low-dose inhaled corticosteroids could benefit from increasing the dosage or adding one of two asthma drugs, a new study by researchers at Washington University School of Medicine and other institutions finds.

3 Mar 2010

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

The Nova Scotia government's decision to limit Pharmacare coverage of blood glucose test strips for some diabetes patients places a significant financial and health burden on these Nova Scotians and violates the fundamental principle that patients and their healthcare professionals should be able to determine how to manage treatment.

3 Mar 2010

Stanford University Medical Center buys ASTI's Ecotones Duet Adaptive Sleep Sound Machines

Adaptive Sound Technologies, Inc. (ASTI) announced today that the Stanford University Medical Center has purchased Ecotones Duet Adaptive Sleep Sound Machines. "It is well known that noise in hospitals affects patient comfort and recovery, as well as staff performance. ASTI's adaptive technology can help with these problems," stated Sam Nicolino, President and CEO of ASTI.

3 Mar 2010

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.

3 Mar 2010

China Nepstar Chain Drugstore reports revenues of US$91 million for fourth-quarter 2009

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2009.

3 Mar 2010

Patient Safety Authority highlights analysis of data related to insulin medication errors

Pennsylvania healthcare facilities submitted over 2,600 event reports that involved the use of insulin products to the Patient Safety Authority where more than 52 percent led to situations in which a patient may have or actually received the wrong dose or no dose of insulin. The data raises awareness of a broader issue that is highlighted in the 2010 March Pennsylvania Patient Safety Advisory.

3 Mar 2010

Instacare announces filing of patent application for MD@Hand technologies

Instacare Corp., a leading provider of prescription drugs, home testing products for the chronically ill, a leading fulfillment provider of direct to patient diabetes programs, and a leading developer of revolutionary cell phone centric e-health products and technologies, today announced that on Friday, February 26, 2010, the Company filed a Provisional Patent Application to secure its MD@Hand technologies.

3 Mar 2010

Lotus Pharmaceuticals adds five new prescription drugs to its products

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that it had added five new prescription drugs to its products delivered through its national sales channels.

3 Mar 2010

Study shows income is not a primary factor in medication adherence

Only 68 percent of corporate executives took their cholesterol lowering medication as prescribed by a doctor, a new study shows.

3 Mar 2010

IntelliDose introduces new, integrated clinical software for medical oncology practices

IntelliDose®, a leading clinical software to manage medical oncology practices, today introduces IntelliScribe™ – a new, fully integrated module in the IntelliDose workflow – to electronically generate prescriptions at any point in the chemotherapy order writing process.

3 Mar 2010

Drugs News and Research

Study indicates ocular shingles may increase stroke risk

Survey underscores need for continued efforts to combat substance abuse among teens

Gene 'addiction' of leukaemia cells

Seattle Genetics generates $110M through ADC technology license agreements

YM BioSciences files Form 6K regarding certain nimotuzumab US patents

PCMA releases statement on GAO report that examines specialty-tier prescription drugs in Medicare Part D

Step-up treatments may benefit children with asthma on low-dose inhaled corticosteroids

Diabetics at risk: Nova Scotia limits pharmacare coverage of blood glucose test strips

Stanford University Medical Center buys ASTI's Ecotones Duet Adaptive Sleep Sound Machines

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

China Nepstar Chain Drugstore reports revenues of US$91 million for fourth-quarter 2009

Patient Safety Authority highlights analysis of data related to insulin medication errors

Instacare announces filing of patent application for MD@Hand technologies

Lotus Pharmaceuticals adds five new prescription drugs to its products

Study shows income is not a primary factor in medication adherence

IntelliDose introduces new, integrated clinical software for medical oncology practices

Enlarged prostate: Dutasteride-tamsulosin combination therapy more effective

Findings could lead to new cancer-fighting drugs

Bisphosphonates may lower risk of breast cancer

Unilife agrees to Exclusivity List; Sanofi-aventis secures exclusivity for Unifill syringe

Drug Discovery - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News